Biosignaling 3 - Video Tutorials & Practice Problems
On a tight schedule?
Get a 10 bullets summary of the topic
concept
Biosignaling 3
Video duration:
11m
Play a video:
Video transcript
Just like cyclic AMP has a bunch of functions in the cell. G also carries out a wide variety of functions and cell signaling and in addition to activating adenylyl cyclase, G protein with GTP bound will also activate phospholipase C which is an enzyme you might remember from the last unit. And, this enzyme cleaves lipids. Hopefully, you remember specifically where it cleaves lipids as that's something that we covered for the last exam. Now phospholipase C, in the case of cell signaling will cleave the bond, between the inositol phosphate and the glycerol of the molecule phosphatidylinositol or abbreviated as PIP2. And you can see that happening right here. We have our G protein coupled receptor, with ligand bound and that this little light thing saying it's, that G is activating phospholipase C PLC, what we see right there. And that's going to cleave this molecule, PIP 2 phospholipase or, sorry, Phosphatidyl inositol. And it's going to cleave it into what's, abbreviated as IP3 or Inositol Triphosphate. What you see right here And it's, also the other sorry, I should say the other part of the molecule after it's cleaved is called diacylglycerol or DAG. So, just to recap, Phospholipase C gets activated by G and it cleaves PIP 2, into DAG and IP 3. Done. Just to note quickly that DAG will stay, in the membrane, whereas IP3 will like exit the membrane, as it is able to, interact with water much better. The other is, you know, very hydrophobic lipid but IP3 has those phosphate groups meaning, it's gonna have a lot of charge so it can interact with water very nicely. So, inositol triphosphate will actually go diffuse into the cell and it will, open up these calcium channels. So here's some sort of internal cell membrane. It's going to, activate these calcium channels so that calcium gets released. And diacylglycerol and calcium, these guys will actually lead to the activation of protein kinase C. Additionally, inositol triphosphate and calcium, will, you know, act as secondary messengers in a variety of other signaling pathways. But just know that calcium and diacylglycerol will activate protein kinase C and know, you know, how how the cleavage of phosphatidylinositol leads to DAG and IP 3. Moving on, we've spent a lot of time on g protein coupled receptors. Now, let's actually take a look at a different type of receptor, called receptor tyrosine kinase or RTK. And these are receptors that are capable of autophosphorylating, meaning they can, phosphorylate themselves and they'll do so at tyrosine residue and, or I should say residues. And they'll do this in response to ligand binding. So we're going to look at insulin as our example of an RTK or the insulin receptor rather as an example of an RTK. And the insulin receptor actually works best as a dimer. And you can see, that we have a nice protein dimer right there meaning that, you know, we have these 2 halves basically coming together to or dimerizing and forming this nice protein dimer that we see there acting as a receptor. And here, we have insulin. That's our ligand. And insulin is going to bind into our receptor phosphorylation cascade. So, let me hop out of the image here. So what you can see happening is, this is autophosphorylate. You can see here that it is autophosphorylate. You can see here that it is going to have a bunch of phosphate groups attached to it. And that's Specifically with insulin, the insulin receptor after it is phosphorylated, it's going to phosphorylate, a protein called IRS1 and IRS1 is going to turn on this, RAS protein complex. So it's a complex of proteins, kind of like all bound together. IRS1 is going to turn on, RAS, the RAS protein complex. The RAS protein complex phosphorylates MEK. MEK phosphorylates ERK and ERK enters the nucleus and activates genes. So basically, insulin binds, the receptor tyrosine kinase does its autophosphorylation and this generates a phosphorylation cascade which ultimately leads to this protein ERK entering the nucleus and activating certain genes leading to the expression of certain genes. Anyways, IRS1 also activates protein kinase B, right? So hopefully you're starting to see a pattern here that, all these components of of signaling pathways tend to do multiple things, right? They don't just have like one simple job. So anyways, IRS1 also activates protein kinase B and that ultimately leads to more glucose transporters specifically GLUT4 transporter in the membrane. So let's, you know back up and think about this for a second. So insulin is released in response to high, sugar levels in your blood. So when insulin is released, it's gonna bind to this receptor tyrosine kinase and, you know, activate a bunch of genes related to, you know, related to processing this sugar basically. Additionally, it's going to activate protein kinase B and protein kinase B is going to put these glucose receptors in the membrane to transport into the cell this high concentration of glucose that is, that is present outside the cell, right? Like in the blood. So, you know, thinking about it on a more medical level, you know, we often say that insulin, lowers blood sugar levels. Well, this is partially how it's doing that by increasing the number of glucose transporters in the membrane thereby taking sugar out of the blood and putting it in the cell. Additionally, insulin, causes glycogen formation because, you know, you have this excess of sugar, you want to store some of it for later because you don't need to burn all of it right away for nutrients. So protein kinase B in addition to causing those GLUT4 receptors to, be integrated into the membrane, protein kinase B also leads to the activation of glycogen synthase. And the way it does that is it actually inactivates GSK3 or glycogen synthase kinase. That's what the GSK is. So it, inactivates GSK3 and that allows glycogen synthase to become active because it's now this is where where things, you know, maybe get a little confusing. So GSK3 is normally, an active protein and its job is to inactivate glycogen synthase. So normally, its GSK 3 is on and it's keeping glycogen synthase off. And it does this by phosphorylating it, right? Here's a great example of where phosphorylating something actually inactivates it. So GSK3 keeps glycogen synthase off by phosphorylating it. But when protein kinase B comes around, it phosphorylates Gsk3 which inactivates Gsk3. And that allows glycogen synthase to actually become active and synthesize glycogen with all that extra glucose. And remember, a lot of glucose is getting transported into the cell now because of those extra glucose transporters. So you can see how this one ligand, right? Insulin is doing a wide variety of things in the cell but they're all kind of related to this, central theme of trying to do something about all that sugar. So, hopefully that, you know, kind of helps illustrate a little bit how, you know, expansive these signaling pathways are and how they can integrate into one another. Alright. Let's flip the page.